About this trial
A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Bone Substitute range of products: CERAFORM, TRIHA+, NANOGEL, and all their private labels.
TEKNIMED bone substitutes are legacy products, some marketed for more than 20 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting.
The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Be 18 years or older.
Be willing to sign an informed consent approved by IRB or EC (where applicable) or not being opposed to the use of their clinical data in the study (France) and
Be considered for a surgery where bone filling with one of the TEKNIMED bone substitutes comprised in this study is needed and intended to be used according to the IFU.
Have undergone a surgery with a TEKNIMED bone substitute used according to the IFU, between the 1st January 2015 and the date of the site initiation visit
Disqualifiers
Under trusteeship or guardianship
Pregnancy or breast-feeding women
Procedures other than those stated in the INDICATIONS section
Patients susceptible to allergic reactions to the product components.
Trial population
People presenting a bone defect created by surgical or traumatic injury.
Trial design
Cohort
Other
Treatments tested in this trial
Bone defect
DeviceBone grafting is a procedure where damaged bones can be repaired or rebuilt using transplanted bone from another source. Sources for transplant bone include the patient (autograft), a cadaver (allograft) or synthetic bone.
Spine fusion
DeviceSpinal fusion is a surgery procedure that reinforces your back structure and stability by linking two vertebrae together
Cage filling
DeviceIntervertebral fusion with cages is a surgical procedure used to stabilize the spine by fusing adjacent vertebrae. The cages, typically made of materials like titanium or plastic, and pre-filled with bone graft substitutes are placed between the vertebrae to maintain the proper spacing and alignment.
Treatment groups
8
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Successful bone repair
Evaluated through the rate of revision surgery due to a failure of the substitute.
Secondary outcomes
Alleviation of Pain
Pain evaluated by Visual Analogue Scale (VAS): on a scale of 0 to 10, with 0 being no pain and 10 being the most severe pain at the Baseline and at the Follow-up visits
Bone reconstruction
Evaluated on X-Rays by the Lane and Shadu score and the healing stage
Well-being
Evaluated through a series of short questions : On a scale from 0 (Not at all) to 10 (Perfectly well) 1. Are you satisfied with your global health status? \_\_\_\_\_ / 10 2. Do you manage to carry out your day-to-day activities? \_\_\_\_\_ / 10 3. Do you manage to achieve what you would like? \_\_\_\_\_ / 10 4. Do you feel relaxed \_\_\_\_\_ / 10 5. Do you feel fit / with energy? \_\_\_\_\_ / 10 6. Do your physical, psychic and emotional conditions allow you to enjoy your relationships with others? \_\_\_\_\_ / 10
Patient satisfaction
Evaluated through a series of short questions A. Are you satisfied with your surgery? YES/NO/Without opinion B. Has your health improved? YES/STABLE/NO C. Given the results, would you do this intervention again? YES/NO/Without opinion